Atrial septal defect. Clinical guidelines 2023

Association of Cardiovascular Surgeons of Russia Russian Society of Cardiology (RSC)

Association of Pediatric Cardiologists of Russia

Russian Scientific Society of Specialists in X-Ray Endovascular Diagnostics and Treatment

All-Russian Public Organization for the Promotion of Radiation Diagnostics and Therapy "Russian Society of Radiologists and Radiologists".

Task Force members declared no financial support/conflicts of interest. If conflicts of interest were reported, the member(s) of the working group was (were) excluded from the discussion of the sections related to the area of conflict of interest.

1. Geva T, Martins JD, Wald RM. Atrial septal defects. Lancet. 2014;383(9932):1921–32. doi:10.1016/S0140-6736(13)62145-5.

2. Rigby M. Atrial septal defect. In: Diagnosis and Management of Adult Congenital Heart Disease. London: Churchill Livingston. 2003:163–78.

3. Schwerzmann M, Pfammatter JP. Approaching atrial septal defects in pulmonary hypertension. Expert Rev Cardiovasc Ther. 2015;13(6):693–701. doi:10.1586/14779072.2015.1047763.

4. Ward R, Jones D, Haponik EF. Paradoxical embolism. An underrecognized problem. Chest. 1995;108:549–58. doi:10.1378/chest.108.2.549.

5. Hoffman JIE, Kaplan S. The incidence of congenital heart disease. J Am Coll Cardiol. 2002;39:1890–900. doi:10.1016/s0735-1097(02)01886-7.

6. Kouchoukos NT, Blackstone EH, Hanley FL, Kirklin JK. Kirklin/Barratt-Boyes cardiac surgery: morphology, diagnostic criteria, natural history, techniques, results, and indications. 4th ed. Philadelphia: Elsevier. 2013.

7. Park MK. Pediatric Cardiology for Practitioners. Mosby; 6 edition. 2014:688.

8. Kupryashov AA. Atrial septal defect. Partial abnormal drainage of the pulmonary veins. In: Bokeria L. A., Shatalov K. V. (ed.). Pediatric cardiac surgery. A guide for doctors. A. N. Bakulev NCSSH of the Ministry of Health of the Russian Federation, 2016, pp. 294–312. (In Russ.)

9. Sharykin AS. Congenital heart defects. Guidelines for pediatricians, cardiologists, neonatologists. M.: Teremok; 2005. (In Russ.)

10. Benson DW, Sharkey A, Fatkin D, et al. Reduced penetrance, variable expressivity, and genetic heterogeneity of familial atrial septal defects.Circulation. 1998;97:2043–8. doi:10.1161/01.cir.97.20.2043.

11. Weil J. Guidelines for the Management of Congenital Heart Diseases in Childhood and Adolescence. Cardiology in the Young. 2017;27(Suppl. 3): S1-S105.

12. Stout KK, Daniels CJ, Aboulhosn JA, et al. 2018 AHA/ACC Guideline for the Management of Adults With Congenital Heart Disease: A Report of the American College of Cardiology/ American Heart Association Task Force on Clinical Practice Guidelines. Circulation. 2019;139: e698-e800. doi:10.1016/j.jacc.2018.08.1029. Erratum in: J Am Coll Cardiol. 2019;73(18):2361–2.

13. Loscalzo J. Paradoxical embolism: clinical presentation, diagnostic strategies, and therapeutic options. Am Heart J. 1986;112:141–5. doi:10.1016/0002-8703(86)90692-7.

14. Baumgartner H, De Backer J, Babu-Narayan SV, et al. 2020 ESC Guidelines for the management of adult congenital heart disease The Task Force for the management of adult congenital heart disease of the European Society of Cardiology (ESC). Eur Heart J. 2021;42(6):563–645. doi:10.1093/eurheartj/ehaa554.

15. Prystowsky EN, Benson DW Jr, Fuster V, et al. Management of patients with atrial fibrillation. A statement for healthcare professionals. From the Subcommittee on Electrocardiography and Electrophysiology, American Heart Association. Circulation. 1996;93:1262–77. doi:10.1161/01.cir.93.6.1262.

16. Kaemmerer H, Apitz C, Brockmeier K, et al. Pulmonary hypertension in adults with congenital heart disease: Updated recommendations from the Cologne Consensus Conference 2018. Int J Cardiol. 2018;272S:79–88. doi:10.1016/j.ijcard.2018.08.078.

17. Baumgartner H, Falk V, Bax JJ, et al. 2017 ESC/EACTS Guidelines for the management of valvular heart disease. Eur Heart J. 2017;38(36):2739–91. doi:10.1093/eurheartj/ehx391.

18. Knuuti J, Wijns W, Saraste A, et al. 2019 ESC Guidelines for the diagnosis and management of chronic coronary syndromes. Eur Heart J. 2020;41(3):407–77. doi:10.1093/eurheartj/ehz425.

19. Sarquella-Brugada G, Blomstrom-Lundqvist C, Deanfield J, et al. Pharmacological and non-pharmacological therapy for arrhythmias in the pediatric population: EHRA and AEPC-Arrhythmia Working Group joint consensus statement. European Heart Rhythm Association; Association for European Paediatric and Congenital Cardiology. Europace. 2013;15(9):1337–82. doi:10.1093/europace/eut082.

20. Bokeria LA, Golukhova EZ, Popov SV, et al. 2020 Clinical practice guidelines for Supraventricular tachycardia in adults. Russian Journal of Cardiology. 2021;26(5):4484. (In Russ.) doi:10.15829/1560-4071-2021-4484.

21. Arakelyan MG, Bockeria LA, Vasilieva EYu, et al. 2020 Clinical guidelines for Atrial fibrillation and atrial flutter. Russian Journal of Cardiology. 2021;26(7):4594. (In Russ.) doi:10.15829/1560-4071-2021-4594.

22. Avdeev SN, Barbarash OL, Bautin AE, et al. 2020 Clinical practice guidelines for Pulmonary hypertension, including chronic thromboembolic pulmonary hypertension. Russian Journal of Cardiology. 2021;26(12):4683. (In Russ.). doi:10.15829/1560-4071-2021-4683.

23. Frost A, Badesch D, Gibbs JSR, et al. Diagnosis of pulmonary hypertension. Eur Respir J. 2019;53(1). doi:10.1183/13993003.01904-2018.

24. Galiè N, Humbert M, Vachiery JL, et al. 2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension: The Joint Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS). Eur. Heart. J. 2016;37(1):67–119. doi:10.1093/eurheartj/ehv317.

25. Gatzoulis MA, Beghetti M, Galiè N, et al.; BREATHE-5 Investigators. Longer-term bosentan therapy improves functional capacity in Eisenmenger syndrome: results of the BREATHE-5 open-label extension study. Int J Cardiol. 2008;127(1):27–32. doi:10.1016/j.ijcard.2007.04.078.

26. Kirchhof P, Benussi S, Kotecha D, et al. 2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS. Europace. 2016;18(11):1609–78. doi:10.1093/europace/euw295.

27. X-ray endovascular surgery. National Guide: in four volumes. Edited by B. G. Alekyan. Moscow. 2017, 2250c. (In Russ.)

28. Du ZD, Hijazi ZM, Kleinman CS, et al. Comparison between transcatheter and surgical closure of secundum atrial septal defect in children and adults: results of a multicenter nonrandomized trial. J. Am. Coll. Cardiol. 2002;39:1836–44. doi:10.1016/s07351097(02)01862-4.

29. Fischer G, Stieh J, Uebing A, et al. Experience with transcatheter closure of secundum atrial septal defects using the Amplatzer septal occluder: a single centre study in 236 consecutive patients. Heart. 2003;89:199–204. doi:10.1136/heart.89.2.199.

30. Dhillon R, Thanopoulos B, Tsaousis G, et al. Transcatheter closure of atrial septal defects in adults with the Amplatzer septal occluder. Heart. 1999;82:559–62. doi:10.1136/hrt.82.5.559.

31. Lopes AA, O'Leary PW. Measurement, interpretation and use of haemodynamic parameters in pulmonary hypertension associated with congenital cardiac disease. Cardiol Young. 2009;19(5):431–5. doi:10.1017/S1047951109990771.

32. Calkins H, Kuck KH, Cappato R, et al. 2012 HRS/EHRA/ECAS Expert Consensus Statement on Catheter and Surgical Ablation of Atrial Fibrillation: recommendations for patient selection, procedural techniques, patient management and follow-up, definitions, endpoints, and research trial design. Europace. 2012;14:528–606. doi:10.1093/europace/eus027.

33. VanHare GF, Ackerman MJ, Evangelista JK, et al. Eligibility and Disqualification Recommendations for Competitive Athletes With Cardiovascular Abnormalities: Task Force 4: Congenital Heart Disease: A Scientific Statement From the American Heart Association and American College of Cardiology. Circulation. 2015;132: e281-e291. doi:10.1161/CIR.0000000000000240.

34. Private physiotherapy. Edited by Professor G. N. Ponomarenko. M.: Medicine. 2005. pp. 426–30. (In Russ.)

35. Physical and rehabilitation medicine. National leadership. Short edition. Edited by G. N. Ponomarenko. M.: GEOTAR-Media, 2017. 512 p. Chapter 21. Khan M. A., Kuyantseva L. V. Diseases of the cardiovascular system. pp. 447–52. (In Russ.)

36. Spa treatment: a national guide. Edited by A. N. Razumov, V. I. Starodubov, G. N. Ponomarenko. M.: GEOTAR-Media, 2021. pp. 593–6. (In Russ.) doi:10.33029/9704-6654-4-SKK-2022-1-704.

37. Gierat-Haponiuk K, Haponiuk I, Szalewska D, et al. Effect of complex cardiac rehabilitation on physical activity and quality of life during long-term follow-up after surgical correction of congenital heart disease. Kardiol Pol. 2015;73(4):267–73. doi:10.5603/KP.a2014.0206.

38. Bjarnason-Wehrens B, Dordel S, Sreeram N, Brockmeier K. Cardiac Rehabilitation in Congenital Heart Disease. In: Perk, J., et al. Cardiovascular Prevention and Rehabilitation. Springer, London. 2007. doi:10.1007/978-1-84628-502-8_45.

39. Ponomarenko GN, Kovlen DV. Physical and rehabilitation medicine. Clinical recommendations based on evidence: 3rd ed., reprint, add. Ed. akad. A. N. Razumova. M.: Nauka, 2020. pp. 10–22. (In Russ.)

40. Golubova TF, Lyubchik VN, Eliseeva LV. Rehabilitation potential of children who underwent surgical correction of congenital heart defects in different age periods. Bulletin of New Medical Technologies. Electronic edition. 2014;(1):213. (In Russ.)

41. Tikkanen AU, Oyaga AR, Riaño OA, et al. Paediatric cardiac rehabilitation in congenital heart disease: a systematic review. Cardiol Young. 2012;22(3):241–50. doi:10.1017/S1047951111002010.

42. Shlyk NI. Therapeutic physical culture in diseases of the cardiovascular system: an educational and methodical manual. Izhevsk: Publishing House "Udmurt University", 2014. p. 114. (In Russ.) EDN SNEXSD.

43. Takken T, Giardini A, Reybrouck T, et al. Recommendations for physical activity, recreation sport, and exercise training in paediatric patients with congenital heart disease: a report from the Exercise, Basic & Translational Research Section of the European Association of Cardiovascular Prevention and Rehabilitation, the European Congenital Heart and Lung Exercise Group, and the Association for European Paediatric Cardiology. Eur J Prev Cardiol. 2012;19(5):1034–65. doi:10.1177/1741826711420000.

44. Karpov VY, Zavalishina SY, Romanova AV, et al. Congenital Heart Defects in Children and the Main Approaches to Rehabilitation After their Surgical Treatment. Indian Journal of Public Health Research & Development. 2019;10(10):1303–7. doi:10.5958/09765506.2019.03013.4. EDN MFHSFI.

45. Kaladze NN, Yushchenko AYu. Dynamics of quality of life indicators in children with ventricular septal defect during sanatorium treatment. Bulletin of Physiotherapy and Balneology. 2020;26(2):26–30. (In Russ.) EDN PXHHOP.

46. Giglia TM, Massicotte MP, Tweddell JS, et al.; American Heart Association Congenital Heart Defects Committee of the Council on Cardiovascular Disease in the Young, Council on Cardiovascular and Stroke Nursing, Council on Epidemiology and Prevention, and Stroke Council. Prevention and treatment of thrombosis in pediatric and congenital heart disease: a scientific statement from the American Heart Association. Circulation. 2013;128(24):2622–703. doi:10.1161/01.cir.0000436140.77832.7a.

47. Habib G, Lancellotti P, Antunes MJ, et al. 2015 ESC Guidelines for the management of infective endocarditis: The Task Force for the Management of Infective Endocarditis of the European Society of Cardiology (ESC).Endorsed by: European Association for Cardio-Thoracic Surgery (EACTS), the European Association of Nuclear Medicine (EANM). European Heart Journal. 2015;36(44):3075–128. doi:10.1093/eurheartj/ehv319.

48. Rehabilitation of patients after surgical treatment of congenital heart defects. 2nd edition, expanded. Moscow: A. N. Bakulev Scientific Center for Cardiovascular Surgery of the Russian Academy of Medical Sciences, 2015. 192 p. (In Russ.) ISBN 978-5-7982-0350-5. EDN VLDTYL.